Consultation outcome

Regulatory fees for medicines: 2016 to 2017 and fees for online sellers of medicines

This consultation has concluded

Original consultation

Summary

This consultation seeks views on the reduction of some fees for the regulation of medicines and the introduction of fees for online sellers of medicines (MLX 389).

This consultation ran from
to